Andrea started his carrier as drug designer in academia before joining Organon, a global pharmaceutical company in the Netherlands. He earned his degree in MD, Computational Chemestry from University of Catania and then in Medicinal and Pharmaceutical Chemistry from University of Pavia.
Andrea leads the Business Unit R&D Platforms and Services of Dompé Pharmaceuticals and is the coordinator of Dompés EXSCALATE research and development project utilizing the most powerful and cost-efficient intelligent supercomputing platform in the world. He has also been responsible for the Joint Bioinformatics Groups at the IBP Institute of the National Research Council of Italy since 2015.
During the past ten years, Andrea has been responsible for developing proprietary computational tools such as LiGen™, GPCRBase™, and LigandBase™ and most recently was the Principal Investigator of two EU-funded projects -- EXSCALATE4COV and LIGATE.
Focused on the potential value of high-performance computing in healthcare, Andrea coordinated and promoted the Italian Drug Discovery Network, open innovation initiative. He co-founded and is a member of the Avicenna Alliance (Brussel) board, an association of industry and research institutions focused on developing in silico simulations up to a scale necessary to provide personalized treatments and predictive medicine. Originator and chairman of the Computational Driven Drug Discovery and Italian Drug Discovery Summit series of meetings, Andrea has co-organized several initiatives with the European Commission and Parliament.